COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,822 Articles (22,968 medRxiv, 8,854 bioRxiv)

Most recent first Previous |  Page 3062: Articles 30611-30620  | Next

Quantifying the effect of quarantine control in Covid-19 infectious spread using machine learning
Dandekar, R., Barbastathis, G.
10.1101/2020.04.03.20052084 — Posted: 2020-04-06 Discussion: Onsite
Using curvature to infer COVID-19 fractal epidemic network fragility and systemic risk
de Souza, D. B., Santos, F. A. N., Figueiroa, E., Correia, J. B., da Silva, H. P., Filho, J. L. d. L., Albuquerque, J.
10.1101/2020.04.01.20047225 — Posted: 2020-04-06
Predicting clinical needs derived from the COVID-19 pandemic: the case of Spain
Hierro-Recio, L. A., Garzon-Gordon, A. J., Atienza-Montero, P., Marquez, J. L.
10.1101/2020.04.03.20051821 — Posted: 2020-04-06
COVID-19 epidemic: Power law spread and flattening of the curve
Verma, M. K., Asad, A., Chatterjee, S.
10.1101/2020.04.02.20051680 — Posted: 2020-04-06
Predictions for COVID-19 outbreak in India using Epidemiological models
Ranjan, R.
10.1101/2020.04.02.20051466 — Posted: 2020-04-06 Discussion: Onsite
Chaos theory applied to the outbreak of Covid-19: an ancillary approach to decision-making in pandemic context
Mangiarotti, S., Peyre, M., Zhang, Y., Huc, M., Roger, F., Kerr, Y.
10.1101/2020.04.02.20051441 — Posted: 2020-04-06
Evidence that higher temperatures are associated with lower incidence of COVID-19 in pandemic state, cumulative cases reported up to March 27, 2020
Triplett, M.
10.1101/2020.04.02.20051524 — Posted: 2020-04-06 Discussion: Onsite
What does simple power law kinetics tell about our response to coronavirus pandemic?
Jha, P. K.
10.1101/2020.04.03.20051797 — Posted: 2020-04-06
Cryptic transmission of SARS-CoV-2 in Washington State
Bedford, T., Greninger, A. L., Roychoudhury, P., Starita, L. M., Famulare, M., Huang, M., Nalla, A., Pepper, G., Reinhardt, A., Xie, H., Shrestha, L., Nguyen, T. N., Adler, A., Brandstetter, E., Cho, S., Giroux, D., Han, P. D., Fay, K., Frazar, C. D., Ilcisin, M., Lacombe, K., Lee, J., Kiavand, A., Richardson, M., Sibley, T. R., Truong, M., Wolf, C. R., Nickerson, D. A., Rieder, M. J., Englund, J. A., Hadfield, J., Hodcroft, E. B., Huddleston, J., Moncla, L. H., Müller, N. F., Neher, R. A., Deng, X., Gu, W., Federman, S., Chiu, C., Duchin, J., Gautom, R., Melly, G., Hiatt, B., Dykema, P., Lindquist, S., Queen, K., Tao, Y., Uehara, A., Tong, S., MacCannell, D., Armstrong, G. L., Baird, G. S., Chu, H. Y., Shendure, J., Jerome, K. R., the Seattle Flu Study Investigators
10.1101/2020.04.02.20051417 — Posted: 2020-04-06 Discussion: Offsite
Rapid implementation of mobile technology for real-time epidemiology of COVID-19
Drew, D. A., Nguyen, L. H., Steves, C. J., Wolf, J., Spector, T. D., Chan, A. T., COPE Consortium
10.1101/2020.04.02.20051334 — Posted: 2020-04-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).